Although plasma concentrations of high-density lipoprotein (HDL) cholesterol correlate
inversely with the incidence of atherosclerotic cardiovascular disease, results from recent …

Plasma levels of high-density lipoprotein (HDL) are strongly and inversely correlated with
atherosclerotic cardiovascular diseases. However, it is becoming clear that a functional HDL …

Low plasma levels of high-density lipoprotein (HDL) cholesterol are associated with
increased risks of coronary heart disease. HDL mediates cholesterol efflux from …

High-density lipoprotein (HDL) plays a central role in vascular biology. HDL participates in
multiple pathways that may be involved in the development of atherosclerosis and coronary …

Reduced plasma levels of HDL-C are associated with an increased risk of CAD and
myocardial infarction, as shown in various prospective population studies. However, recent …

High-density lipoproteins (HDL) are classified as atheroprotective because they are involved
in transport of cholesterol to the liver, known as “reverse cholesterol transport (RCT)” …

High-density lipoproteins (HDL) possess key atheroprotective biological properties,
including cellular cholesterol efflux capacity, and anti-oxidative and anti-inflammatory …

The concept of raising high-density lipoprotein (HDL) has been the focus of increasing
attention as a strategy to reduce cardiovascular disease. HDL particles are, however, highly …

The high-density lipoproteins (HDLs) are complex, polymolecular assemblies produced by
the jejunum, liver, in serum, and on the surface of macrophages. HDL cholesterol (HDL-C) …

Plasma high density lipoprotein cholesterol (HDL) comprises a heterogeneous family of
lipoprotein species, differing in surface charge, size and lipid and protein compositions …